Morepen Laboratories Limited (BOM:500288)
India · Delayed Price · Currency is INR 51.02
-0.50 (-0.97%)
At close: Jun 18, 2026
Morepen Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 948.77 | 1,180 | 961.6 | 386.75 | 1,017 |
Depreciation & Amortization | 364.35 | 286.7 | 334.7 | 279.3 | 276.43 |
Other Amortization | - | 3.12 | - | - | - |
Loss (Gain) From Sale of Assets | -247.21 | 1.52 | - | - | -3.6 |
Loss (Gain) From Sale of Investments | -10.96 | - | - | - | - |
Other Operating Activities | 233.73 | 85.92 | 23.29 | 5.01 | -77.38 |
Change in Accounts Receivable | -501.24 | 1.75 | -616.91 | -126.04 | -686.59 |
Change in Inventory | 175.65 | -513.71 | -197.08 | 469.68 | -1,005 |
Change in Other Net Operating Assets | -628.97 | -724.98 | 232.76 | -1,926 | -122.81 |
Operating Cash Flow | 326.42 | 320.57 | 733.75 | -911.71 | -602.4 |
Operating Cash Flow Growth | 1.83% | -56.31% | - | - | - |
Capital Expenditures | -855.23 | -1,240 | -713.81 | -356.21 | -454.46 |
Sale of Property, Plant & Equipment | 10.54 | 0.51 | 0.53 | - | 1.67 |
Sale (Purchase) of Intangibles | -750.2 | -902.04 | -99.55 | -103.51 | -219.22 |
Investment in Securities | 793.89 | -836.8 | -13.01 | - | 15.41 |
Other Investing Activities | -433.16 | -236.41 | -7.17 | -5.37 | 339.81 |
Investing Cash Flow | -1,234 | -3,215 | -833 | -465.09 | -316.79 |
Short-Term Debt Issued | - | 279.99 | 14.05 | 69.83 | 10.31 |
Long-Term Debt Issued | 1,318 | 480.97 | 24.31 | - | 4.93 |
Total Debt Issued | 1,318 | 760.96 | 38.35 | 69.83 | 15.23 |
Short-Term Debt Repaid | -90.85 | - | - | - | - |
Long-Term Debt Repaid | -130.03 | - | - | -3.88 | - |
Total Debt Repaid | -220.88 | - | - | -3.88 | - |
Net Debt Issued (Repaid) | 1,097 | 760.96 | 38.35 | 65.95 | 15.23 |
Issuance of Common Stock | - | 1,907 | - | - | - |
Common Dividends Paid | -108.58 | - | - | - | - |
Dividends Paid | -108.58 | - | - | - | - |
Other Financing Activities | -14.39 | 330.6 | 13.7 | 1,369 | 648.11 |
Financing Cash Flow | 973.98 | 2,999 | 52.05 | 1,435 | 663.34 |
Miscellaneous Cash Flow Adjustments | -28.15 | - | - | - | - |
Net Cash Flow | 38.09 | 104.36 | -47.21 | 58.63 | -255.84 |
Free Cash Flow | -528.81 | -919.76 | 19.94 | -1,268 | -1,057 |
Free Cash Flow Margin | -2.93% | -5.08% | 0.12% | -8.92% | -6.79% |
Free Cash Flow Per Share | -0.96 | -1.72 | 0.04 | -2.52 | -2.03 |
Cash Interest Paid | - | 77.85 | 37.1 | 19.81 | 24.26 |
Cash Income Tax Paid | 252.79 | 371.52 | 381.15 | 165.54 | 249.32 |
Levered Free Cash Flow | -1,108 | -2,231 | -300.86 | -278.55 | -1,440 |
Unlevered Free Cash Flow | -1,006 | -2,183 | -277.67 | -266.17 | -1,424 |
Change in Working Capital | -954.56 | -1,237 | -581.23 | -1,583 | -1,815 |